Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01010750 · ClinicalTrials.gov registry record · Phase 1
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
A Phase 1 study of Attention Deficit Hyperactivity Disorder, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT01010750 is a Phase 1 study of Attention Deficit Hyperactivity Disorder that has completed, run by Shire. The registered enrollment target is 18 participants, below the 207-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01010750, a Phase 1 study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the sensitivity and responsiveness of a standardized, validated, computer-based, battery of neuro-psychometric tests in adults with ADHD.
Conditions Studied
Interventions
- DRUG Lisdexamfetamine Dimesylate (LDX)
- DRUG Immediate Release Mixed Amphetamine Salts (MAS-IR)
- DRUG LDX Placebo + MAS-IR Placebo
Study Locations (1)
Texas
- Claghorn-Lesem Research Clinic - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-01-05 |
| Est. Completion | 2010-03-28 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01010750
The ClinicalTrials.gov registry entry for NCT01010750 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 207-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (91% lower). The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 3 interventions - of which Lisdexamfetamine Dimesylate (LDX) is the first listed.
NCT01010750 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01010750 about?
NCT01010750 is a clinical study titled "Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)". To evaluate the sensitivity and responsiveness of a standardized, validated, computer-based, battery of neuro-psychometric tests in adults with ADHD.
What is the current status of trial NCT01010750?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2010-01-05. Estimated completion is 2010-03-28.
What conditions does trial NCT01010750 study?
This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.
What interventions are being tested in trial NCT01010750?
The interventions under investigation include: Lisdexamfetamine Dimesylate (LDX) (DRUG), Immediate Release Mixed Amphetamine Salts (MAS-IR) (DRUG), LDX Placebo + MAS-IR Placebo (DRUG).
Who is sponsoring clinical trial NCT01010750?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01010750 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Hyperactivity Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
RECRUITING · Phase 1
-
Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder
COMPLETED · Phase 1
-
Task-Based Grounding Program
COMPLETED · Phase 1
-
Developing Brain, Impulsivity and Compulsivity
RECRUITING
-
HOPS Study: A Conceptual Replication
RECRUITING · NA
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.